Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improving Psychological Distress Among Critical Illness Survivors and Their Caregivers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01983254
Recruitment Status : Completed
First Posted : November 13, 2013
Results First Posted : April 4, 2017
Last Update Posted : January 21, 2020
Sponsor:
Collaborators:
University of North Carolina, Chapel Hill
University of Pittsburgh
University of Washington
Patient-Centered Outcomes Research Institute
Information provided by (Responsible Party):
Duke University

Brief Summary:
Patients who receive life support in intensive care units commonly suffer from persistent depression, anxiety, and post-traumatic stress disorder (PTSD) symptoms after discharge. We are trying to learn which is a better way to manage this distress: a telephone-based adaptive coping skills training program or an educational program.

Condition or disease Intervention/treatment Phase
Intensive Care Unit Survivors Informal Caregivers (Family and Friends) Behavioral: coping skills training Other: education program Not Applicable

Detailed Description:

Public Summary of Research Project Why is this important? Nearly 800,000 Americans receive mechanical ventilation for acute respiratory failure in the ICU each year. Afterward, over half of both patients and their family caregivers suffer from psychological distress (depression, anxiety, and post-traumatic stress ["PTSD"]) for over 1 year after discharge. Patients and families told us that they need help with their distress because it worsens their quality of life. More specifically, patients said that learning how to adapt (that is, how to cope) with the physical and emotional changes of critical illness would be helpful. In fact, most ICU survivors use coping skills infrequently, which worsens psychological distress. But patients also told us that they wanted more information about critical illness, recovery, and what to expect. A lack of information increases PTSD symptoms. However, there are few treatments for this distress that can overcome ICU survivors' physical disability, great distance from expert medical centers, and concerns about how much treatments would cost. Therefore, we developed two treatments to address coping and lack of information.

What is the main goal? We aim to compare which of two treatments are more effective in reducing psychological distress and improving quality of life. One is a coping skills training (CST) program provided by telephone. The other is an education program about critical illness that is accessed primarily online. Also, we will determine if unique groups of people with special characteristics have especially good improvement-and if so, what personal factors explain this response.

How will we know which treatment is better? We will determine which treatment is most helpful by comparing participants' levels of psychological distress and quality of life with surveys taken over 6 months. We'll also record patients' own descriptions of how the treatments impacted their daily lives. The study will take 3 years and would be performed at 5 medical centers across the US that treat patients with diverse backgrounds and illnesses. 200 ICU survivor-family member pairs will be randomly assigned (like a coin flip) to receive either the CST program or the education program. Treatments consist of 6 weekly telephone calls with a trained staff member, web-based modules, and handouts.

How will this help others in the future? This research is important because it aims to improve long-term recovery for entire families by focusing on a devastating, common, yet inadequately addressed problem. These treatments were developed with the direct input of patients and families. These treatments represent a new direction in treating critical illness because they can be delivered inexpensively by phone, easily adapted to future technologies, overcome barriers to care common to ICU survivors, and shared easily by phone or computer with others in need across the world.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 417 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Improving Psychological Distress Among Critical Illness Survivors and Their Caregivers
Study Start Date : October 2013
Actual Primary Completion Date : February 2016
Actual Study Completion Date : April 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety Caregivers

Arm Intervention/treatment
Experimental: Coping skills training
6 sessions of weekly telephone-based coping skills training delivered by trained interventionist
Behavioral: coping skills training
6-session coping skills training program delivered by telephone w/ web augmentation

Active Comparator: education program
6 week access to a web-based, critical illness-specific education program
Other: education program
web-based, ICU-specific education program




Primary Outcome Measures :
  1. Hospital Anxiety and Depression Scale Score [ Time Frame: 3 & 6 months post-randomization ]
    Hospital Anxiety and Depression Scale (HADS) questionnaire: The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale. The 3 month measure is primary outcome timing, though changes at 6 months will be tested as well


Secondary Outcome Measures :
  1. Impact of Events Scale-revised (IES-R) Score [ Time Frame: 3 & 6 months post-randomization ]
    The IES-R evaluates subjective distress caused by traumatic events and assesses manifestations of post-traumatic stress disorder (PTSD) or acute stress disorder. It is not diagnostic but possesses excellent reliability and validity for manifestations of PTSD. The IES-R has three subscales (eight items on intrusion, eight items on avoidance, and six items on hyperarousal). Each item is scored on a four point scale: 0 = "not at all," 1 = "a little bit," 2 = "moderately often," 3 = "quite a bit," and 4 = "extremely often." The total score of each subscale may be averaged and a cumulative score of 30 is indicative of the presence of PTSD. The maximum score for each subscale is 32 for intrusion, 32 for avoidance, and 24 for hyperarousal. The minimum cumulative score is 0 and the maximum cumulative score possible is 88.3 months post-randomization is main time point while The 3 month IES-R score will be the primary analysis, though 6 month changes will be tested as well.


Other Outcome Measures:
  1. Total Weeks at Home Post-randomization [ Time Frame: over 6 months follow up ]
    here reported as weeks (instead of days) not at home for simplicity



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Patient inclusion criteria:

  • age >=18 and
  • mechanical ventilation for more than 48 consecutive hours

Patient exclusions (pre-consent):

  • current significant cognitive impairment (>=3 errors on the Callahan scale) or lacks decisional capacity
  • pre-existing significant cognitive impairment
  • residence at location other than home before hospital admission
  • need for a translator because of poor English fluency [many study instruments are not validated in other languages]
  • expected survival <3 months
  • discharged to hospice (outpatient or inpatient)
  • not liberated from mechanical ventilation at discharge

Additional patient exclusion criteria (present post-consent but pre-randomization):

  • Patients will become ineligible if they become too ill to participate
  • they develop significant cognitive disability, exhibit suicidality, they do not return home within 2 months after hospital discharge, or die.

Informal caregiver inclusion criteria:

  • age >=18 years
  • person most likely to provide the most post-discharge care.

Exclusions for caregivers are:

  • history of significant cognitive impairment
  • English fluency poor enough to require a medical translator

Informal caregiver exclusion criteria present after consent but before randomization:

  • no longer available
  • become too ill to participate
  • exhibit suicidality

A total of 200 patient-caregiver dyads (total cohort = 400) are targeted


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01983254


Locations
Layout table for location information
United States, North Carolina
University of North Carolina
Chapel Hill, North Carolina, United States, 27599
Duke University
Durham, North Carolina, United States, 27710
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261
United States, Washington
University of Washington
Seattle, Washington, United States, 98195
Sponsors and Collaborators
Duke University
University of North Carolina, Chapel Hill
University of Pittsburgh
University of Washington
Patient-Centered Outcomes Research Institute
Investigators
Layout table for investigator information
Principal Investigator: Christopher E Cox, MD MPH Duke University
Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: Duke University
ClinicalTrials.gov Identifier: NCT01983254    
Other Study ID Numbers: Pro00043171
PCORI PFA 195 ( Other Grant/Funding Number: PCORI PFA 195 )
First Posted: November 13, 2013    Key Record Dates
Results First Posted: April 4, 2017
Last Update Posted: January 21, 2020
Last Verified: January 2020
Keywords provided by Duke University:
coping
acute respiratory failure
critical illness
depression
anxiety
post-traumatic stress
intensive care unit
Additional relevant MeSH terms:
Layout table for MeSH terms
Critical Illness
Disease Attributes
Pathologic Processes